Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intraperitoneal nebulized ropivacaine for postoperative pain after laparoscopic cholecystectomy
2008-002029-36Phase 3Completed
- Sponsor
- Fondazione IRCCS San Gerardo dei Tintori
- Start
- Apr 2008
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised trial of ropivacaine in postoperative pain and cholelithiasis (4 arms), sponsored by Fondazione IRCCS San Gerardo dei Tintori. Primary endpoint: Reduction in postoperative pain within 48 hours after laparoscopic cholecystectomy. Started Apr 2008; status: completed.
02
Drugs
ropivacaine
03
Conditions
postoperative paincholelithiasis
Beyond the preview
Go deeper on 2008-002029-36.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2008-002029-36.